Skip to content
Recall Observatory FDA recall evidence

Device product

VaccZyme Human Anti-Haemophilus influenza type b Enzyme Immunoassay Kit For in vitro diagnostic use, Product Code: MK016 - Product Usage: This assay is designed for the in vitro measurement of specific IgG antibodies against Haemophilus influenzae type b (Hib) capsular polysaccharide, present in human serum. Sufficient materials are supplied to allow a maximum of 41 samples to be tested in duplicate, with a calibration curve and two controls.

Z-1469-2020

August 12, 2018

Class II

Product summary

Firm
The Binding Site Group, Ltd.
Event
Event 84899
Status
Terminated
Classification
Class II
Quantity
462 kits
Official record key
device-enforcement:Z-1469-2020

Official wording

Reason: A deterioration of performance was identified with influenza type B Enzyme Immunoassay Kits with findings of a positive bias with kit controls. Patient sample results may be affected with falsely elevated results incorrectly indicating a protective level of anti-Hib antibody in the assessment of immunodeficiency.

Code information: UDI: 05051700006767. Lot numbers 413170 and 435314.

Distribution pattern: Worldwide distribution - US Nationwide distribution in the states of M.A., C.A., MO., NC, MN, VA, WA, and IL and country of Canada.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    A deterioration of performance was identified with influenza type B Enzyme Immunoassay Kits with findings of a positive bias with kit controls. Patient sample results may be affected with falsely elevated results incorrectly indicating a protective level of anti-Hib antibody in the assessment of immunodeficiency.